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Abstract Connexins belong to the family of gap junction
proteins which enable direct cell-to-cell communication
by forming channels in adjacent cells. Mutations in
connexin genes cause a variety of human diseases and,
in a few cases, result in skin disorders. There are signif-
icant differences in the clinical picture of two rare auto-
somal dominant syndromes: keratitis–ichthyosis–deafness
(KID) syndrome and hidrotic ectodermal dysplasia
(Clouston syndrome), which are caused by GJB2 and
GJB6 mutations, respectively. This is despite the fact
that, in both cases, malfunctioning of the same family
proteins and some overlapping clinical features (nail
dystrophy, hair loss, and palmoplantar keratoderma) is
observed. KID syndrome is characterized by progressive
vascularizing keratitis, ichthyosiform erythrokeratoderma,
and neurosensory hearing loss, whereas Clouston syn-
drome is characterized by nail dystrophy, hypotrichosis,
and palmoplantar keratoderma. The present paper pre-
sents a Polish patient with sporadic KID syndrome
caused by the mutation of p.Asp50Asn in GJB2. The
patient encountered difficulties in obtaining a correct
diagnosis. The other case presented is that of a family
with Clouston syndrome (caused by p.Gly11Arg
mutation in GJB6), who are the first reported patients
of Polish origin suffering from this disorder. Phenotype
diversity among patients with the same genotypes report-
ed to date is also summarized. The conclusion is that
proper diagnosis of these syndromes is still challenging
and should always be followed by molecular verification.
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Introduction
Two rare congenital disorders, keratitis–ichthyosis–deafness
(KID) syndrome [OMIM 148210] and Clouston syndrome
(hidrotic ectodermal dysplasia 2) [OMIM 129500], are caused
by mutations in genes coding connexin proteins (GJB2 and
GJB6, respectively), and both of them have skin
manifestation.
Despite the malfunctioning of proteins from the same
family and some overlapping of such clinical features as nail
dystrophy, hair loss, and palmoplantar keratoderma, the clin-
ical picture of these syndromes differs significantly.
KID syndrome is a very rare congenital autosomal domi-
nant disorder of keratinization with abnormal differentiation
of the epidermis and aberrant formation of the cornified layer.
The illness is characterized by progressive vascularizing ker-
atitis, ichthyosiform erythrokeratoderma, and neurosensory
hearing loss.
Most patients with KID syndrome are sporadic; only about
100 have been reported so far. The syndrome was first de-
scribed in 1915 by Frederick S. Burns in a 16-year-old boy
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with congenital atypical ichthyosiform erythrokeratoderma,
palmoplantar keratosis, and sensorineural hearing loss (Burns
1915). The term “KID syndrome” was later introduced as an
acronym of the first letters of the main clinical symptoms.
There are, however, arguments that this acronym does not
define the disorder precisely; for example, changes in the skin
are not ichthyosis but ichthyosis-like erythrokeratoderma, and
keratitis can be absent at the onset of the illness (Skinner et al.
1981).
Clouston syndrome, or hidrotic ectodermal dysplasia,
is another autosomal dominant rare disorder character-
ized by nail dystrophy, hypotrichosis, and palmoplantar
keratoderma. The clinical expression can vary, but nails
are predominantly affected. They are thick, hyperplastic,
and deformed with onycholysis. Hair is dry, fine, and
brittle, and may be absent from the scalp, axillary, and
pubic region. Moderate to severe hyperkeratosis is often
present, with reduced keratinocytes desquamation (Kibar
et al. 1996). Sweating and the teeth are normal (Hassed
et al. 1996).
Two cases are described in the present paper: that of a
Polish patient with sporadic KID syndrome who encountered
difficulties in obtaining a correct diagnosis and a family with




The proband is the first and only child of nonconsanguineous
parents. He was born at 35 weeks of gestation after pregnancy
complicated by the mother’s hypertension and a herpes sim-
plex infection. His birth weight was 2,630 g (25th–50th
centile), length 51 cm (95th centile), head circumference
32 cm (25th–50th centile), the Apgar score was 6 points in
the 1st minute and 8 points in the 5th minute. The audiologic
screening after birth revealed deafness. He was noted to have
generally hyperkeratotic skin, especially thick on the back,
and congenital ichthyosis was suspected. In the second week,
a very thick hyperkeratotic layer of the skin on the back was
removed by the parents during his bath. Histopathologic in-
vestigation of skin biopsy did not confirm ichthyosis. The next
suspected disease was Netherton syndrome, but the patient’s
hair evaluation did not reveal bamboo hair, which is typical for
this syndrome. Menkes syndrome was also considered in the
differential diagnosis elsewhere.
The boy was examined for the first time in the Genetics
Department of the Institute of Mother and Child in Warsaw
(Poland) in the 4th year of his life (Fig. 1). He had hyperker-
atotic skin all over the body but especially over his joints,
Fig 1 Phenotype characteristics
of patient 1: a, d wart-like
hyperkeratotic plaques on an
erythematous base on the cheek,
ears, and chin; b reticulated
hyperkeratosis on the hands with
normal nails; c hyperkeratotic
skin over elbow; e acanthosis
nigricans in the axillary region
and around the nipple
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reticulated hyperkeratosis on the hands and feet, with normal
nails. Wart-like hyperkeratotic plaques on an erythematous
base, which were initially interpreted as ichthyotic but, in fact,
turned out to be ichthyosis-like erythrokeratoderma, were
symmetrically located on the cheeks, ears, and chin. He also
had deep furrows around the mouth and eyes. Eyebrows,
eyelashes, and body hair were absent. His scalp hair was stiff
and dry. Acanthosis nigricans in the axillary and inner elbow
regions and also around the nipples was observed. The patient
manifested sensorineural hearing loss, photophobia,
hypohidrosis, and increased susceptibility to cutaneous infec-
tions. His dentition was regular. Ophthalmologic examination
at the age of 5 years did not reveal keratitis. Somatic and
psychomotor development was normal. The diagnosis of KID
syndrome was suggested.
Patient 2
The proband is the first and only child of nonconsanguineous
parents. He was born at 41 weeks of gestation after an un-
complicated pregnancy. His birth weight was 3,820 g (75th
centile), length 56 cm (>95th centile), head circumference
32 cm (5th centile), the Apgar score was 9 points in the 1st
minute. and 10 points in the 3rd minute. At the age of
8 months, he was admitted to the Genetic Counseling Depart-
ment of the Institute of Mother and Child in Warsaw because
of hypotonia and retardation in motor development. Physical
examination showed dysplastic nails of the fingers and toes,
but the hair, eyebrows, and eyelashes were normal (Fig. 2).
His head circumference was within the normal range. Cerebral
ultrasound at the age of 6 months was described as normal and
the psychomotor development of this child at the age of 4 years
was normal.
Patient 3
The patient was the 30-year-old father of patient 2 who had
never been diagnosed previously. He had partial alopecia and
sparse eyebrows and eyelashes. His nails were thickened and
dysplastic, with subungual hyperkeratosis, severe curvature,
and yellow discoloration. The skin of his palms and soles was
hyperkeratotic and mildly hyperpigmented on the joints.
Sweating and teeth were normal. The patient had normal
eyebrows and eyelashes in his early childhood, and then he
lost them. Progressive hair loss began after the age of 22 years.
Several members of this family were also affected (his brother,
mother, and uncle) (Fig. 3). His mother has similar signs, apart
from hair, which was present (it was, however, always sparse).
The diagnosis of familial Clouston syndrome was suggested.
Methods
In the three patients described herein, DNAwas isolated from
peripheral blood leukocytes using Genomic Maxi AX (A&A
Fig. 2 Phenotype characteristics
of patients 2, a, b dysplastic nails
and toes, and 3, c thickened,
dysplastic nails, d plantar
hyperkeratosis, d partial alopecia,
sparse eyebrows and eyelashes,
normal teeth
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Biotechnology). A mutation analysis based on Sanger se-
quencing of the coding exon of theGJB2 gene was performed
in patient 1 and of the GJB6 gene in patients 2 and 3 (primer
sequences available on request). Fluorochromatograms were
analyzed in Mutation Surveyor software (SoftGenetics) using
NM_004004.5 and NM_006783.4 as reference sequences.
The parents of patients 1 and 2, and patient 3 gave informed
consent to participate in the study and to publish the patient
photographs.
Results
The results of DNA analysis in the three patients confirmed
the clinical diagnosis of KID syndrome in patient 1 [hetero-
zygous mutation p.Asp50Asn (c.148G>A) in GJB2] and
Clouston syndrome in patients 2 and 3 [mutation p.Gly11Arg
(c.31G>C) in GJB6].
Discussion
The present study describes patients with very rare genetic
disorders caused by mutations in the connexin genes: KID
syndrome caused by a de novo mutation p.Asp50Asn in the
GJB2 gene and familial Clouston syndrome caused by a
mutation of p.Gly11Arg in the GJB6 gene inherited from the
proband’s father. The clinical manifestations of both syn-
dromes vary, but manifestations in the skin and its appendages
are predominant (Table 1) (Caceres-Rios et al. 1996).
Skin lesions in KID syndrome can be seen from birth as
red, dry, wrinkled skin with wart-like or hyperkeratotic
plaques of erythrokeratoderma. The natural history of this
syndrome is characterized by chronic bacterial and fungal skin
and mucous membrane infections, with a sometimes fatal
course in the first year of life (Gilliam and Williams 2002;
Janecke et al. 2005) and later by a higher risk of squamous cell
carcinoma (SCC) of the skin and oral mucosa (Hazen et al.
1989). Despite being the major symptoms in KID syndrome,
erythrokeratoderma and deafness are also characteristic for the
other disorder caused by mutations in genes coding connexin
Cx31 (GJB3; OMIM 603324) and Cx30.3 (GJB4; OMIM
605425)—erythrokeratoderma variabilis of Mendes da Costa;
however, keratitis is not part of this syndrome. In KID syn-
drome, keratitis and corneal vascularization may appear later
in life (at the onset of puberty) and can progress to blindness
(Gómez-Faiña et al. 2006). Moreover, KID syndrome is the
only connexin disorder which is associated with a risk of at
least 12 % that SCC can develop. An early diagnosis of this
syndrome is, thus, essential to avoid irreversible eye damage
and to support patients with regular oncological monitoring
(Avshalumova et al. 2014).
Several mutations in the GJB2 gene causing KID syn-
drome are known: p.Gly11Arg, p.Gly12Arg, p.Asn14Tyr,
p.Ser17Phe, p.Ala40Val, p.Asp50Asn, and p.Gly54Glu
Fig. 3 Pedigree of the family of
patients 2 and 3 with Clouston
syndrome. Affected males are
represented with filled squares
and affected females with filled
circles
Table 1 Diagnostic criteria for keratitis–ichthyosis–deafness (KID)
syndrome (minor criteria may not be present) (Caceres-Rios et al. 1996)
Major criteria
Erythrokeratoderma (100 %)
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localized in the N-terminus or in the first extracellular domain
(Xu and Nicholson 2013). The mutation p.Asp50Asn of high-
ly conserved aspartic acid in codon 50 responsible for “clas-
sical” KID features is identified in most KID patients (Xu and
Nicholson 2013). The p.Asp50Asn substitution results from
spontaneous methylation and deamination of cysteine in the
hypermutable CpG dinucleotide of codon 50.
Although phenotype changes vary over time and manifest
different symptoms (even within one family), which results in
difficulties in making the correct clinical diagnosis, several
patients with p.Asp50Asn mutation in GJB2 have common
leading clinical signs (Table 2). The median age of 25 (out of
26) patients with this mutation presented in the literature is
20 years old (range 10months to 54 years). In 18 of them, skin
manifestation was reported to be present at birth. Hearing
impairment developed in all the patients and was designated
as profound except for three of them (aged 10, 13, and 42 years
old, respectively), in whom it was reported as mild or moder-
ate. Among the skin findingsmost abundant were: generalized
thickened skin, palmoplantar keratoderma, erythematous
verrucous plaques, epidermal cysts, and hyperkeratotic lesions
(scalp). In 27 % (6/26) of the patients, skin carcinomas were
observed, although in the group of adult patients, skin carci-
nomas were observed in 54 % of patients. Irrespective of age,
ocular findings were reported in at least 70 % (18/26) of the
patients.
The degree of difficulty in recognizing KID and in
distinguishing the overlapping clinical signs in various skin
disorders is well illustrated by the history of patient 1 de-
scribed in the present study. Over a period of four years from
his birth, he had four different clinical diagnoses (X-linked
ichthyosis, Netherton syndrome, Menkes syndrome, and
ichthyosis again) before the correct diagnosis when KID was
finally confirmed.
In the differential diagnostics of KID syndrome, other
disorders should also be considered: the classic form of
Vohwinkel syndrome (OMIM 124500) with congenital deaf-
ness, keratopachydermia, constrictions of fingers and toes,
and palmoplantar keratoderma with deafness (OMIM
148350), which are also caused by GJB2 mutations. Never-
theless, despite the substantial clinical overlap, some differ-
ences exist between them as well: keratitis is absent in both of
them and keratoderma is limited to the hands, feet, elbows,
and knees in the former and to the palms and soles only in the
latter syndrome. Furthermore, according to the observation of
van Geel et al. (2002) the p.Asp50Asn mutation in GJB2 can
also cause hystrix-like ichthyosis with deafness (HID), where
keratitis is not observed either. Such phenotypic discrepancy
between KID and HID and the otherGJB2-caused disorders is
poorly understood, but may cause further prolongation of the
diagnostic process.
In the case of patient 2, the diagnostic process was shorter,
but not very easy, because at the age of 8 months, the patient
had only mild clinical expression of the disease—mildly
dystrophic nails which could easily have been mistaken for
pachyonychia congenita. Immediate correct diagnosis was
only possible after clinical examination of the patient’s father,
who has, unlike other relatives, severely dysplastic nails,
palmoplantar hyperkeratosis, alopecia, and lack of eyebrows
and eyelashes. It should be noted, however, that, despite those
symptoms, Clouston syndrome had never previously been
suggested in the patient’s father. Indeed, only around 30
patients with Clouston syndrome have been published, with
very limited phenotypic data available, which makes diagnos-
tics more challenging. Furthermore, several other rare hair–
nail ectodermal dysplasias have been identified, which should
also be taken into consideration in the diagnostic process, e.g.,
autosomal recessive “pili torti and onychodysplasia” (OMIM
602032; Calzavara-Pinton et al. 1991), congenital nail dystro-
phy, hypotrichosis of the scalp with folliculitis decalvans
(Barbareschi et al. (1997), and pachyonychia congenita
(OMIM 167200). The latter has recently been shown to be
falsely recognized in seven patients instead of Clouston syn-
drome (Hale et al. 2014). Last but not least, KID syndrome
diagnosis should also be excluded (van Steensel et al. 2004).
KID and Clouston syndromes are caused by mutation in
different connexin genes; however, their symptoms partially
overlap (nail dystrophy, hair loss, and palmoplantar kerato-
derma). This can be due to their function, structure, and ability
to cooperate, forming heteromeric (composed of more than
one connexin type) connexons.
Connexins belong to the family of gap junction proteins,
which enable direct cell-to-cell communication by forming
channels in adjacent cells. Hence, they are crucial for main-
taining tissue homeostasis, growth control, development, and
synchronized response of cell stimuli. Up to now, at least 20
genes of human connexins are known, but skin disorders are
only connected with mutations in GJB2 (Cx26), GJB6
(Cx30), GJB3 (Cx31), GJB4 (Cx30.3), and GJA1 (Cx43).
Cx26 and Cx30 share a 76 % identity and have a structure
typical for connexins: four transmembrane hydrophobic do-
mains, two extracellular highly conserved hydrophilic loops,
and three relatively variable cytoplasmic domains (Jan et al.
2004).
Mutations p.Gly11Arg in GJB6 and p.Asp50Asn in GJB2
are located in the N-terminus of Cx30 and in the first extra-
cellular domain of Cx26, respectively. Both domains face pore
channels and, thus, mutations in these regions can lead to
changes in connexon conductance or even loss of channel
function (for details, see Oshima et al. 2011, Levit et al.
2012, and Essenfelder et al. 2004).
While theGJB2 genemutations associated with skin symp-
toms all cause deafness, mutations in the GJB6 gene result in
skin disease, usually without hearing impairment (van
Steensel et al. 2004). This can be explained by connexin
redundancy. In the inner ear, the wild type of connexin 26
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can compensate for the lack of activity of mutated connexin
30, but not in the skin. Such compensation is not possible in
the opposite direction, either in the skin or in the inner ear. The
key to clarifying this phenomenon is different permeability for
ions for both the homotypic (composed of one connexin type)
and heterotypic (composed of more than one connexin type)
connexons. Therefore, mutated Cx26 exerts a dominant neg-
ative effect on the wild type of other co-expressed connexins,
like, for example, on Cx30 in the skin. Cohen-Salmon et al.
(2002) concluded that epithelial gap junctions containing
Cx26 are essential for the cochlear function and cell survival.
This observation and explanation is complicated by the find-
ing of Jan et al. (2004), who described a case of KID syn-
drome with sensorineural hearing loss and congenital atrichia
caused bymutation in the geneGJB6 (Cx30), which is usually
connected with Clouston syndrome. Similarly, Sugiura et al.
(2013) described a patient with Clouston syndrome and sen-
sorineural hearing loss and photophobia, but in this patient,
apart from mutation in the GJB6 gene, the GJB2 gene variant
was found. Another patient with a phenotype resembling
Clouston syndrome but with deafness and mutation in the
GJB2 gene was described by van Steensel et al. (2004). To
establish a genotype–phenotype correlation in gap junction
skin syndromes, further studies and observations are needed.
New gap junction syndromes of the skin are still being de-
scribed, which can have a great significance for establishing
this correlation (de Zwart-Storm et al. 2011).
It seems that there are still some unrecognized disor-
ders of the skin to be discovered by inquisitive genet-
icists and dermatologists, who should also clinically
evaluate the pedigree of family members and verify
clinical recognition using molecular techniques. Similar-
ly, the genetic background of several clinically distin-
guished disorders, including around 70 % of about 170–
200 known ectodermal dysplasias, still lacks genetic
explanation (Visinoni et al. 2009; Irvine 2009).
The conclusion was drawn that the proper diagnosis
of gap junction syndromic skin disorders is still a chal-
lenge, especially due to the extremely low incidence of
this disorder [no patient of Polish origin with Clouston
syndrome and only one with KID-like syndrome (de
Zwart-Storm et al. 2011) had been described in the
literature before]. However, it can be neither neglected
nor underestimated due to variable prognosis and highly
differing health complications that may occur (like SCC
in KID syndrome).
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